CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1670.45-26.9 (-1.58 %)
PREV CLOSE ( ) 1697.35
OPEN PRICE ( ) 1700.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4021
TODAY'S LOW / HIGH ( )1652.00 1700.55
52 WK LOW / HIGH ( )900 1793.5
NSE1672.55-23.65 (-1.39 %)
PREV CLOSE( ) 1696.20
OPEN PRICE ( ) 1706.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1672.55 (89)
VOLUME 34139
TODAY'S LOW / HIGH( ) 1631.30 1706.20
52 WK LOW / HIGH ( )900.05 1799
( in Million)
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax4125.653220.132375.183127.202134.90
Adjustment374.32465.51527.95180.37122.67
Changes In working Capital-811.80-522.86-220.53-887.63-218.46
Cash Flow after changes in Working Capital3688.173162.782682.602419.942039.10
Cash Flow from Operating Activities2654.672460.022074.751668.171548.07
Cash Flow from Investing Activities-1546.09-1579.50-1117.88-1952.05-1127.43
Cash Flow from Financing Activities-992.15-852.19-1001.64311.24-434.15
Net Cash Inflow / Outflow116.4328.32-44.7727.36-13.51
Opening Cash & Cash Equivalents34.996.6751.4424.0837.60
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent151.4234.996.6751.4424.09

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.